Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://saulwjaj973362.blogacep.com/44495155/trelaglutide-exploring-a-new-therapy-for-chronic-diseases